about
A conserved domain of herpes simplex virus ICP34.5 regulates protein phosphatase complex in mammalian cellsImmune cell screening of a nanoparticle library improves atherosclerosis therapyMyeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice.A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer NanomedicinesHyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in AtherosclerosisMultifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer.Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.Evaluation of [18F]-ATRi as PET tracer for in vivo imaging of ATR in mouse models of brain cancer.Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.Nanomedical Theranostics in Cardiovascular Disease.HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophagesInhibiting macrophage proliferation suppresses atherosclerotic plaque inflammationImaging Macrophage and Hematopoietic Progenitor Proliferation in AtherosclerosisPET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein NanoparticlesNanoreporter PET predicts the efficacy of anti-cancer nanotherapy.Near-Infrared Intraoperative Chemiluminescence Imaging.Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.Near-infrared fluorescence energy transfer imaging of nanoparticle accumulation and dissociation kinetics in tumor-bearing mice.A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation.Fluorescent nanoparticles for the accurate detection of drug delivery.Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis.Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal ImagingConformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids.Targeted PET imaging strategy to differentiate malignant from inflamed lymph nodes in diffuse large B-cell lymphoma.In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.Comprehensive analysis of the clinical immuno-oncology landscape.Author Correction: Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primatesEfficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primatesSonophore-enhanced nanoemulsions for optoacoustic imaging of cancerThe calponin homology domain of Vav1 associates with calmodulin and is prerequisite to T cell antigen receptor-induced calcium release in Jurkat T lymphocytesTrends in clinical development for PD-1/PD-L1 inhibitorsImmuno-oncology drug development goes globalImaging-assisted nanoimmunotherapy for atherosclerosis in multiple species
P50
Q24302506-FB28E33E-E19B-48E4-9ADA-A22283D4D91CQ28393434-9E1DC896-6D66-456D-9013-E38E1994BD9EQ33607097-64177940-1523-456E-AAAE-C852E2935A6EQ33615407-B4C47945-24E5-426D-A2B9-FA0D55DB66C4Q33856678-7A5EE2D5-F932-4434-B1EF-3AFC59296320Q33894213-4ACE6A3B-8828-4B57-B3B2-FF7B12C92D8BQ33924365-7BD40745-53EE-43C4-9ADF-C779B448EDB6Q33925006-86433D58-28C4-4A55-85B9-E51AB3ED3E0FQ33949943-E4292D17-1E71-412E-AFA4-1DA4A9E9818DQ35681183-20D44D48-356C-4481-99FE-2DACA74F55C1Q35795262-0454909F-7D60-4C8E-90A3-C44BE22D5A62Q35964485-595ABFA1-ED39-4A9F-8FE2-5AC69DF70225Q36202794-7A9C943F-80DC-4BFF-8378-E768D6BBC35FQ36533549-BA1C6332-EA18-4493-9BC8-72A72DD173A1Q37024507-49F6191A-A735-4E53-AFB3-0EB4ECECDADAQ37333843-69E513D3-AB4E-435C-A56F-0626A543FB67Q37393282-87248D76-726F-47D6-8088-204E2EBF219FQ37626750-E51DD974-FC4D-4692-86F4-A815DA27C003Q37727091-5052CEAA-142E-4409-A196-43441E731CB5Q38570366-085CEC9E-0AFF-4E94-AE2A-4EA142513C1CQ38890074-F0F83A1B-6300-45C9-86EC-30040D0B53D2Q38895968-35ACC1C0-9C5C-482B-98D9-7087C9AF01DBQ41268340-EC5E8269-F8B3-4738-BD69-1209198D0619Q41269380-5030FF3E-71A1-4E61-A7EE-F516245ADA79Q41534056-1F6041F8-144E-4936-B241-D9746528CBF6Q47269284-D3B7B5F6-719A-47C6-9D23-F40FCBC782E8Q47330557-02940C0A-70D8-4BDF-8025-A7D50941E0ABQ63560432-1FCB7B89-84BD-4757-A306-F268C4E231CDQ63560435-7DBDBE6E-D705-4B5E-B075-C89335D3669EQ64218610-7841AD64-D3C9-41EF-A864-95FC179FFE16Q80433057-52F350A5-3DDE-4757-B77E-264183B00A15Q90010534-205966A8-0BC8-4C71-8067-A1C260E04988Q91526932-0B72EF94-1F84-4AAE-9FA2-DE92AE1D9F96Q92756293-3AC8D02D-69E5-4F59-BB96-52C0F0BDB63C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jun Tang
@ast
Jun Tang
@en
Jun Tang
@es
Jun Tang
@sl
type
label
Jun Tang
@ast
Jun Tang
@en
Jun Tang
@es
Jun Tang
@sl
prefLabel
Jun Tang
@ast
Jun Tang
@en
Jun Tang
@es
Jun Tang
@sl
P106
P1153
55713899400
P1960
JRx_NFcAAAAJ
P31
P496
0000-0002-8285-5111